Gelonghui, March 25 | Lexin Healthcare (300562.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 884 million yuan, a year-on-year decrease of 16.98%; net profit attributable to shareholders of listed companies was 34,3673 million yuan, turning a year-on-year loss into a profit; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses of 225.392 million yuan; basic earnings per share of 0.1597 yuan; plans to distribute a cash dividend of 1.50 yuan (tax included) for every 10 shares to all shareholders